SCHEMBL26388376

SCHEMBL26388376

Cc1nn(CC(F)F)cc1I

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25648965 0.80 PDE2A (0.34) PDE2A
SCHEMBL1662616 0.77 PDE2A (0.33) PDE2A
SCHEMBL24977818 0.77
SCHEMBL26389378 0.77 MAT2A (0.30)
SCHEMBL25647871 0.76 PDE2A (0.33) PDE2A
SCHEMBL24977207 0.75
SCHEMBL26388352 0.74 CSF1R (0.33)
SCHEMBL26388629 0.74
SCHEMBL25109188 0.73 SMN1; SMN2 (0.39) PDE2A
SCHEMBL23880200 0.73 HTT (0.33) PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192901-A9 QUINOLINE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS ESCIENT PHARMACEUTICALS, INC. (US) 2023-12-14 WO disclosed
WO-2023192901-A1 QUINOLINE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS ESCIENT PHARMACEUTICALS, INC. (US) 2023-10-05 WO disclosed